Results Case report A 35-year-old female with GH-secreting pituitary tumors was treated with surgery and medical therapy using the first-generation SSA, octreotide, and the D2 agonist, cabergoline
This new Harvard analysis offers a reassuring message for women who discover they were taking Ozempic, Wegovy, Zepbound, Mounjaro, or another GLP-1 medication before realizing they were pregnant
The dose-dependent increase in GI adverse events is consistent with GLP-1 receptor activation patterns seen with semaglutide and tirzepatide at comparable therapeutic levels
FDA Chair Marty Makary would like to see more prescription medicines available over-the-counter (or without a prescription)
they represent distinct evolutionary steps in incretin biology
At Peak Performance, we primarily prescribe premium-quality compounded GLP-1 medications from state-licensed, FDA-registered compounding pharmacies